A new technique uses stem cells to deliver anti-cancer drugs to aggressive brain tumors that are, otherwise, often inaccessible. This potentially life-saving treatment was developed by UNC pharmacoengineer Shawn Hingtgen.
With new funding, a UNC startup is poised to halt the most devastating effects of chemotherapy.
UNC researchers have discovered a new target for chronic pain treatment.
Two UNC researchers design a biological test to individualize chemotherapy.
UNC’s Patrick Giguere uncovers a single sodium ion that regulates how pain medications work in the brain, a key discovery that carries the promise of a better class of drugs.